tradingkey.logo
tradingkey.logo
Search

Akebia Therapeutics Inc

AKBA
Add to Watchlist
1.220USD
0.0000.00%
Close 07-24 16:00ETQuotes delayed by 15 min
326.84MMarket Cap
LossP/E TTM

AKBA Financials

See Akebia Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Akebia Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.03/-0.03
Revenue / Forecast
53.54M/51.67M
Period
FY2025 Earnings
Revenue(YoY)
236.20M
47.46%
EPS(YoY)
-0.02
93.68%
Analyst Rating
STRONG BUY
2026/07/25
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-230.64%-0.03
55.76%-0.05
102.14%0.00
102.30%0.00
129.57%0.03
-3327.24%-0.10
-23.82%-0.10
31.57%-0.04
39.67%-0.09
106.45%0.00
---0.08
---0.06
---0.15
---0.05
---0.48
----
----
----
----
----
Revenue
-6.61%53.54M
23.93%57.62M
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.26%46.50M
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
2.06%56.20M
-13.69%42.05M
-55.39%56.38M
-35.16%40.01M
-4.53%55.06M
-0.09%48.71M
138.82%126.36M
17.96%61.70M
2.93%57.68M
-18.72%48.76M
-41.30%52.91M
Net Profit
-248.13%-9.05M
46.31%-12.24M
102.69%540.00K
102.88%247.00K
133.98%6.11M
-3814.01%-22.80M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.98M
106.66%614.00K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
86.81%-9.22M
9.15%-54.10M
135.46%29.45M
10.29%-62.42M
20.96%-69.86M
0.69%-59.54M
52.75%-83.04M
Net Margin
-258.63%-16.91%
56.67%-21.25%
101.72%0.92%
102.01%0.40%
119.33%10.66%
-4588.74%-49.04%
-55.37%-53.54%
0.78%-19.66%
17.90%-55.16%
106.53%1.09%
---34.46%
---19.82%
---67.18%
---16.74%
---37.24%
----
----
----
----
----
Gross Margin
-18.73%69.75%
41.56%82.06%
28.43%81.66%
36.76%82.53%
33.96%85.83%
-11.90%57.97%
11.99%63.58%
-11.51%60.34%
31.12%64.07%
-58.23%65.80%
--56.78%
--68.19%
--48.86%
--157.52%
--61.42%
----
----
----
----
----
Debt to assets ratio
256.88%53.51%
193.16%51.40%
184.64%52.71%
214.04%54.24%
12.16%14.99%
22.20%17.53%
2.11%18.52%
3.14%17.27%
-26.41%13.37%
-22.68%14.35%
--18.13%
--16.75%
--18.17%
--18.56%
--30.50%
----
----
----
----
----
Revenue
-6.61%53.54M
23.93%57.62M
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.26%46.50M
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
2.06%56.20M
-13.69%42.05M
-55.39%56.38M
-35.16%40.01M
-4.53%55.06M
-0.09%48.71M
138.82%126.36M
17.96%61.70M
2.93%57.68M
-18.72%48.76M
-41.30%52.91M
Operating profit
-157.58%-7.90M
56.40%-5.45M
135.24%3.95M
270.08%13.99M
196.05%13.71M
-847.13%-12.51M
7.91%-11.21M
6.43%-8.22M
43.32%-14.28M
-92.85%1.67M
75.78%-12.17M
-118.08%-8.79M
56.93%-25.19M
135.83%23.41M
8.49%-50.23M
161.26%48.61M
9.92%-58.49M
2.90%-65.34M
5.52%-54.89M
-36.11%-79.34M
Net Profit
-248.13%-9.05M
46.31%-12.24M
102.69%540.00K
102.88%247.00K
133.98%6.11M
-3814.01%-22.80M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.98M
106.66%614.00K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
86.81%-9.22M
9.15%-54.10M
135.46%29.45M
10.29%-62.42M
20.96%-69.86M
0.69%-59.54M
52.75%-83.04M
Current assets
19.48%243.48M
122.22%252.96M
158.03%258.34M
109.33%234.66M
80.43%203.78M
-3.65%113.83M
-8.65%100.12M
-5.36%112.10M
-6.44%112.94M
-36.20%118.15M
-53.85%109.60M
-61.06%118.45M
-60.12%120.72M
-31.70%185.18M
-28.04%237.51M
-8.13%304.16M
-17.08%302.69M
-27.00%271.15M
-15.58%330.08M
-26.28%331.08M
Total current liabilities
90.61%173.88M
101.37%162.94M
102.98%133.38M
10.64%118.72M
37.21%91.23M
-18.98%80.91M
-17.56%65.71M
16.40%107.30M
-19.84%66.49M
-22.90%99.87M
-57.60%79.70M
-60.55%92.18M
-67.33%82.94M
-50.38%129.54M
-0.66%187.97M
41.12%233.68M
47.04%253.91M
39.49%261.05M
4.27%189.21M
-15.42%165.59M
Total assets
16.87%362.52M
70.65%376.56M
75.80%364.15M
56.95%345.60M
37.57%310.19M
-8.70%220.67M
-11.85%207.14M
-13.21%220.20M
-18.56%225.48M
-32.12%241.70M
-46.09%235.00M
-51.38%253.71M
-48.29%276.86M
-32.74%356.05M
-27.62%435.89M
-14.72%521.80M
-14.85%535.36M
-17.82%529.35M
-10.93%602.27M
-17.89%611.86M
Total liabilities
17.35%335.14M
27.46%343.95M
25.24%322.56M
24.58%316.37M
13.01%285.60M
-0.89%269.86M
-6.15%257.54M
-9.47%253.95M
-13.21%252.74M
-22.39%272.29M
-34.98%274.42M
-38.95%280.52M
-42.81%291.21M
-22.95%350.82M
-9.26%422.04M
5.09%459.50M
22.76%509.24M
14.83%455.34M
29.86%465.12M
16.62%437.23M
Total equity
11.37%27.38M
166.30%32.61M
182.52%41.59M
186.58%29.22M
190.18%24.58M
-60.82%-49.19M
-27.85%-50.40M
-25.91%-33.75M
-89.92%-27.26M
-684.78%-30.58M
-384.57%-39.42M
-143.03%-26.81M
-154.95%-14.35M
-92.93%5.23M
-89.90%13.85M
-64.32%62.30M
-87.79%26.12M
-70.11%74.01M
-56.87%137.15M
-52.84%174.63M
Net operating income
-56.08%-21.21M
797.02%31.13M
519.79%28.11M
321.98%22.34M
30.08%-13.59M
-93.50%-4.47M
6.59%-6.70M
-377.38%-10.07M
-10.80%-19.43M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
18.88%-17.54M
12.94%-54.68M
160.08%33.80M
51.44%-30.66M
69.44%-21.62M
-104.04%-62.81M
-106.59%-56.27M
-269.64%-63.14M
Net investment
-140.26%-62.00K
-393750.00%-7.88M
-3750.00%-77.00K
-334.48%-126.00K
--154.00K
---2.00K
---2.00K
---29.00K
----
--0.00
--0.00
--0.00
100.00%0.00
--0.00
--0.00
-100.00%0.00
-100.57%-114.00K
-100.00%0.00
100.00%0.00
140.00%20.00M
Net financing
-101.24%-926.00K
-121.72%-4.85M
-8.99%1.11M
-77.49%1.72M
305.64%74.94M
1830.62%22.32M
2346.00%1.22M
195.50%7.64M
215.71%18.48M
-128900.00%-1.29M
100.15%50.00K
-88788.89%-8.00M
-133.58%-15.97M
-100.02%-1.00K
-299.84%-32.94M
-100.02%-9.00K
-36.16%47.55M
-82.29%5.40M
1463.76%16.48M
-73.83%37.37M

FAQs

What is the total revenue of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its total revenue reached 236.20M, with a year-on-year change of 160.18M.

What are the current assets of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its current assets were 252.96M, with a year-on-year change of 122.22.

What are the total assets of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its total assets of Akebia Therapeutics Inc were 376.56M, with a year-on-year change of 70.65.

What are the total liabilities of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its total liabilities of Akebia Therapeutics Inc were 343.95M, with a year-on-year change of 27.46.

What is the total equity of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its total equity of Akebia Therapeutics Inc was 32.61M, with a year-on-year change of 166.30.

What is the net operating income of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its net operating income of Akebia Therapeutics Inc was 26.00M, with a year-on-year change of 156.26.

What is the net investment of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its net investment of Akebia Therapeutics Inc was -7.93M, with a year-on-year change of -23918.18.

What is the net financing of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its net financing of Akebia Therapeutics Inc was 72.93M, with a year-on-year change of 46.84.

What is the Earnings Per Share (EPS) of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.02, with a year-on-year change of 93.68.

What is the net income of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its net income was -5.34M, with a year-on-year change of 92.30.

What is the net margin of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its net profit margin was -2.26, with a year-on-year change of 94.78.

What is the gross margin of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its gross margin was 82.91, with a year-on-year change of 35.54.

What is the debt-to-asset ratio of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 51.40, with a year-on-year change of -36.18.

What is the Return on Assets (ROA) of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -1.79, with a year-on-year change of 94.04.

What is the operating profit of Akebia Therapeutics Inc?

According to Akebia Therapeutics Inc's FY2025 earnings report, its operating profit was 26.00M, with a year-on-year change of 156.26.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.